Compugen (CGEN) Cash from Operations (2009 - 2010)
Compugen (CGEN) posted quarterly Cash from Operations of 831000.0 for Q4 2010, up 60.05% year-over-year from 519218.98 in Q4 2009, and down 99.76% on a QoQ basis from 416000.0 in Q3 2010.
Compugen (CGEN) Cash from Operations (2009 - 2010) Analysis & Trends
Compugen has reported Cash from Operations for 2 years, with the latest figure at 831000.0 in Q4 2010.
- Cash from Operations for Q4 2010 came in at 831000.0, up 60.05% year-over-year; the trailing twelve-month figure through Dec 2010 was 4280000.0 (changed N/A YoY), and the FY2025 annual result was 31634000.0, down 36.23% from the prior year.
- Cash from Operations eased to 831000.0 in Q4 2010, from 416000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 416000.0 in Q3 2010 and troughed at 2080000.0 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | -831,000.00 |
| Dec 31, 2010 | -831,000.00 |
| Sep 30, 2010 | -416,000.00 |
| Sep 30, 2010 | -416,000.00 |
| Dec 31, 2009 | -2.08 Mn |
| Dec 31, 2009 | -2.08 Mn |
| Sep 30, 2009 | -953,000.00 |
| Sep 30, 2009 | -953,000.00 |